Oral Abstracts Session 2
Saturday, September 9, 2023 04:30 PM - 05:30 PM
335 AB
Regulatory Affairs, Quality Systems, Policy and Ethics; Exosomes/EVs; Hematopoietic Stem/Progenitor Cells and Engineering; Immunotherapy
Chair
Jaap Jan Boelens, MD, PhD, Transplantation and Cellular Therapies, MSKCC, USA
Presenters
Chair
Jaap Jan Boelens, MD, PhD, Transplantation and Cellular Therapies, MSKCC, USA
Presenters
- Lori Daane, bioMérieux, Inc. – One-Hour Mycoplasma Testing of Product Samples Containing Mammalian Cells Using a Closed-System Molecular Lab in A Pouch
- Mohsen Fathi, University of Houston – Single-Cell EV Profiling with Timing™ Identifies A Gene Signature Associated with Metastatic Breast Cancer
- Devin McAvoy, Memorial Sloan Kettering Cancer Center – Predictors for Recent Thymic Emigrant T Cell Reconstitution after Hematopoietic Cell Transplantation
- Purva Rathi, Baylor College of Medicine – Glypican-3-specific CAR-NKTs overexpressing BATF3 mediate potent antitumor activity against hepatocellular carcinoma
- Xiatong Song, Texas A&M University – Selective refueling of CAR T cells using ADA1 and CD26 boosts antitumor immunity
- Tony Ward, Curate Biosciences – Platelets Induce Regulatory T-Cell Expansion During CAR-T Manufacturing
Jaap Jan Boelens MD, PhD
Pediatric-Oncologist, Chief
Transplantation and Cellular Therapies, MSKCC
Chair
Pediatric-Oncologist, Chief
Transplantation and Cellular Therapies, MSKCC
Chair